Potential therapeutic applications of RNA cap analogs
- PMID: 23795970
- DOI: 10.4155/fmc.13.96
Potential therapeutic applications of RNA cap analogs
Abstract
Cap analogs are chemically modified derivatives of the unique cap structure present at the 5´ end of all eukaryotic mRNAs and several non-coding RNAs. Until recently, cap analogs have served primarily as tools in the study of RNA metabolism. Continuing advances in our understanding of cap biological functions (including RNA stabilization, pre-mRNA splicing, initiation of mRNA translation, as well as cellular transport of mRNAs and snRNAs) and the consequences of the disruption of these processes - resulting in serious medical disorders - have opened new possibilities for pharmaceutical applications of these compounds. In this review, the medicinal potential of cap analogs in areas, such as cancer treatment (including eIF4E targeting and mRNA-based immunotherapy), spinal muscular atrophy treatment, antiviral therapy and the improvement of the localization of nucleus-targeting drugs, are highlighted. Advances achieved to date, challenges, plausible solutions and prospects for the future development of cap analog-based drug design are described.
Similar articles
-
mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation.Nucleic Acids Res. 2017 Sep 6;45(15):8661-8675. doi: 10.1093/nar/gkx569. Nucleic Acids Res. 2017. PMID: 28666355 Free PMC article.
-
High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.RNA. 2005 Jan;11(1):77-89. doi: 10.1261/rna.7108205. RNA. 2005. PMID: 15611299 Free PMC article.
-
Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency.RNA. 2004 Sep;10(9):1479-87. doi: 10.1261/rna.7380904. RNA. 2004. PMID: 15317978 Free PMC article.
-
Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability.Methods Enzymol. 2007;431:203-27. doi: 10.1016/S0076-6879(07)31011-2. Methods Enzymol. 2007. PMID: 17923237 Review.
-
Cap and cap-binding proteins in the control of gene expression.Wiley Interdiscip Rev RNA. 2011 Mar-Apr;2(2):277-98. doi: 10.1002/wrna.52. Epub 2010 Oct 28. Wiley Interdiscip Rev RNA. 2011. PMID: 21957010 Review.
Cited by
-
Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life.RNA. 2019 Apr;25(4):507-518. doi: 10.1261/rna.069286.118. Epub 2019 Jan 15. RNA. 2019. PMID: 30647100 Free PMC article.
-
mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation.Nucleic Acids Res. 2017 Sep 6;45(15):8661-8675. doi: 10.1093/nar/gkx569. Nucleic Acids Res. 2017. PMID: 28666355 Free PMC article.
-
Synthetic mRNA capping.Beilstein J Org Chem. 2017 Dec 20;13:2819-2832. doi: 10.3762/bjoc.13.274. eCollection 2017. Beilstein J Org Chem. 2017. PMID: 30018667 Free PMC article. Review.
-
Synthesis and Evaluation of Diguanosine Cap Analogs Modified at the C8-Position by Suzuki-Miyaura Cross-Coupling: Discovery of 7-Methylguanosine-Based Molecular Rotors.J Org Chem. 2023 Jun 2;88(11):6827-6846. doi: 10.1021/acs.joc.3c00126. Epub 2023 May 20. J Org Chem. 2023. PMID: 37209102 Free PMC article.
-
Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential.Nucleic Acids Res. 2016 Nov 16;44(20):9578-9590. doi: 10.1093/nar/gkw896. Epub 2016 Oct 7. Nucleic Acids Res. 2016. PMID: 27903882 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
